Loading...
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
OBJECTIVE: The obesity epidemic is a public health concern, warranting further research into pharmacological treatments for weight management (WM) as an adjunct to lifestyle interventions. The Semaglutide Treatment Effect in People with obesity (STEP) program aims to investigate the effect of semagl...
Na minha lista:
| Udgivet i: | Obesity (Silver Spring) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7318657/ https://ncbi.nlm.nih.gov/pubmed/32441473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22794 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|